M Megna Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

7/2022	Impact of fixed-dose combination Cal/BD foam on the work productivity of patients with psoriasis: results from the 52-week randomized, double-blind, PSO-LONG trial.
3/2022	Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.
1/2022	Alopecia universalis improvement following risankizumab in a psoriasis patient.
11/2020	Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.
11/2020	QuantiFERON-TB Gold conversion is not uncommon in patients with psoriasis undergoing anti-tumour necrosis factor-α therapy.
10/2020	Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period.
3/2020	Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period.
7/2019	Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
1/2019	Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
1/2017	The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Megna Research Topics

Disease

12	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2022 - 01/2013
2	Pain (Aches) 07/2019 - 01/2012
1	Pemphigus (Pemphigus Vulgaris) 10/2022
1	Alopecia universalis 01/2022
1	Necrosis 11/2020
1	Neoplasms (Cancer) 10/2020
1	Infections 10/2020
1	Hidradenitis Suppurativa 10/2019
1	Mycosis Fungoides 02/2019
1	Psoriatic Arthritis 01/2018
1	Lymphedema (Milroy Disease) 10/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Hepatitis 04/2012
1	Hypoprothrombinemias (Prothrombin Deficiency) 04/2012
1	Depressive Disorder (Melancholia) 01/2012
1	Deglutition Disorders (Dysphagia) 01/2012
1	Urge Urinary Incontinence (Urge Incontinence) 01/2012
1	Flatfoot (Flat Feet) 01/2012
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2012
1	Stroke (Strokes) 01/2012
1	Overactive Urinary Bladder (Overactive Bladder) 01/2012
1	Dysarthria (Spastic Dysarthria) 01/2012
1	Multiple Sclerosis 01/2012
1	Muscle Spasticity (Spastic) 01/2012
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2012
1	Ataxia (Dyssynergia) 01/2012
1	Spasm (Spasms) 01/2012
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2012
1	Torticollis (Wryneck) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 06/2010
1	Dementia (Dementias) 06/2010
1	Body Weight (Weight, Body) 07/2009
1	Neuralgia (Stump Neuralgia) 07/2009
1	Back Pain (Backache) 07/2009
1	Paralysis (Palsy) 07/2009
1	Radiculopathy (Radiculopathy, Cervical) 07/2009

Drug/Important Bio-Agent (IBA)

2	risankizumabIBA 03/2022 - 01/2022
2	Prostaglandins AIBA 07/2019 - 01/2013
2	Type A Botulinum Toxins (Botox)FDA Link 01/2012 - 01/2012
1	BNT162 VaccineIBA 10/2022
1	tildrakizumabIBA 03/2022
1	InterleukinsIBA 03/2022
1	guselkumabIBA 03/2022
1	apremilastIBA 11/2020
1	GoldIBA 11/2020
1	secukinumabIBA 10/2020
1	ixekizumabIBA 03/2020
1	Adalimumab (Humira)FDA Link 10/2019
1	EmollientsIBA 07/2019
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 07/2019
1	calcipotriene (calcipotriol)FDA LinkGeneric 07/2019
1	AerosolsIBA 07/2019
1	InterferonsIBA 02/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2018
1	Etanercept (Enbrel)FDA Link 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 07/2016
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 04/2012
1	Solifenacin Succinate FDA Link 01/2012
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2012
1	incobotulinumtoxinA FDA Link 01/2012
1	Muscarinic AntagonistsIBA 01/2012
1	amsonic acid (DAS)IBA 01/2012
1	oxybutynin (Tavor)FDA LinkGeneric 01/2012
1	trospium chloride (Ceris)FDA LinkGeneric 01/2012
1	Therapeutic UsesIBA 01/2012
1	Baclofen FDA LinkGeneric 01/2012
1	Antidepressive Agents (Antidepressants)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	CytokinesIBA 06/2010
1	Thioctic Acid (Lipoic Acid)IBA 07/2009
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2009
1	gamma-Linolenic AcidIBA 07/2009

Therapy/Procedure

9	Therapeutics 07/2022 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2009
1	Polypharmacy 10/2020
1	Radical Mastectomy 10/2013
1	Speech Therapy (Therapy, Speech) 01/2012
1	Activities of Daily Living (ADL) 01/2012